{
    "nct_id": "NCT03657069",
    "official_title": "A Pilot Study of Applying New Device Technologies for Tissue Expander/Implant-Based Breast Reconstruction (Blossom Syringe Assist Device)",
    "inclusion_criteria": "* Diagnosis of breast cancer or reason for prophylactic mastectomy (e.g., BRCA mutation and/or strong family history of breast cancer), both unilateral or bilateral mastectomy\n* No prior breast surgery (excluding biopsy and lumpectomy) or breast radiation\n* Ability to understand and the willingness to sign a written informed consent document\n* No life expectancy restrictions\n* Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status will not be employed\n* No requirements for organ and marrow function\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Recent steroid use\n* No major medical comorbidities (defined as American Society of Anesthesiologists [ASA] III or greater)\n* No connective tissue disorder\n* Prior breast surgery, excluding biopsy and lumpectomy\n* History of or plan for breast radiation\n* Pregnancy and nursing patients will be excluded from the study\n* No restrictions regarding use of other investigational agents\n* No exclusion criteria related to history of allergic reactions\n* No exclusion criteria relating to concomitant medications or substances that have the potential to affect the activity or pharmacokinetics of the study agent\n* No other agent-specific exclusion criteria\n* No exclusion of cancer survivors or those who are human immunodeficiency virus (HIV)-positive",
    "miscellaneous_criteria": ""
}